All articles tagged with "Risk Analysis"
Four hospital operators, four business models, 14x ROIC spread. HCA's scale generates 19.2% returns. THC's ambulatory surgery centers deliver 16.8% margins. UHS's behavioral health focus shows improving trends—but deteriorating litigation risk. CYH's rural model is structurally broken. Static ROIC analysis misses the risk velocity layer that determines which returns are sustainable.
CrowdStrike's 10-Q tells a rare story: risk factors that are actively materializing. Two risks escalated, one is new, and zero have been resolved. The July 19 incident created $101M+ in expenses, litigation with no disclosed maximum exposure, and management admissions that read like warnings, not disclaimers. This is a test case for reading risk factors seriously.
The conventional wisdom says NuScale (SMR) is safer because it has NRC approval. But filing data reveals SMR paid $495M—$6.9M per reactor—to trigger a non-binding customer agreement. OKLO has regulatory uncertainty but uncommitted cash.
VST's +321% appreciation prices in nuclear optionality, but ignores a $510M battery fire disaster and antitrust lawsuit. CEG's 'capacity price boom' masks 970bps margin spread between regions. TLN's 0.9x interest coverage means debt service consumes nearly ALL operating income. We analyzed 9 filings to surface what the market overlooks.
AVGO's top 5 customers account for 40% of revenue. NVDA's largest customer is 22%. ANET depends on Microsoft (20%) and Meta (15%). Standard AI stock screens show none of this. Here's our 2-signal framework for stress-testing AI beneficiaries.